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Accepted 8 September 2015; Published online 21 September 2015AbstractObjectives: Prediction models may facilitate risk-based management of health care conditions. In a large cluster-randomized trial, pre-
senting calculated risks of postoperative nausea and vomiting (PONV) to physicians (assistive approach) increased risk-based management
of PONV. This increase did not improve patient outcomedthat is, PONV incidence. This prompted us to explore how prediction tools guide
the decision-making process of physicians.
Study Design and Setting: Using mixed methods, we interviewed eight physicians to understand how predicted risks were perceived
by the physicians and how they influenced decision making. Subsequently, all 57 physicians of the trial were surveyed for how the presented
risks influenced their perceptions.
Results: Although the prediction tool made physicians more aware of PONV prevention, the physicians reported three barriers to use
predicted risks in their decision making. PONV was not considered an outcome of utmost importance; decision making on PONV prophy-
laxis was mostly intuitive rather than risk based; prediction models do not weigh benefits and risks of prophylactic drugs.
Conclusion: Combining probabilistic output of the model with their clinical experience may be difficult for physicians, especially when
their decision-making process is mostly intuitive. Adding recommendations to predicted risks (directive approach) was considered an
important step to facilitate the uptake of a prediction tool.  2016 Elsevier Inc. All rights reserved.
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0895-4356/ 2016 Elsevier Inc. All rights reserved.of having a current condition (i.e., a diagnostic model) or
predict a future health condition (i.e., prognostic model).
This information may then be used by health care providers
and patientsdideally in shared decision makingdto decide
on the most appropriate course of action, either treatment,
preventive strategies, or a combination of these. It is often
recommended that before widespread use in daily practice,
the actual impact of diagnostic or prognostic prediction
models on clinical decision making and patient outcomes
should be formally studied in the so-called ‘‘prediction
model impact studies.’’ [1e5] We recently performed a
large impact study of the implementation of a prediction
model. This impact study allowed us to explore how clini-
cians actually perceive the use of prediction models and use
their predicted risks in their decision making.
The impact study was designed as a large cluster-
randomized trial on theuseof a previouslydeveloped, validated,
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 Conscious integration of a predicted risk into a
physician‟s decision-making process may be diffi-
cult and require a lot of attention. In a high-work-
load environment it is important to consider how
the prediction model may be accommodated in
the workflow of physicians to ease its attentional
demands. Adding actionable recommendations to
predicted risks and provide the reasoning behind
the risk may reduce these demands and improve
the uptake of the prediction model.
T.H. Kappen et al. / Journal of Cliand recalibrated prediction model for postoperative nausea
and vomiting (PONV) [6,7]. PONV is a common problem
in the first 24 hours after surgery with general anesthesia,
affectingdon averaged30% of all surgical patients
[6,8,9]. At the start of anesthesia, physicians who were ran-
domized to the intervention group were ‘‘exposed’’ to
model-based risk estimates of PONV for their individual
patients, as calculated by an online prediction model. When
compared with the unexposed physiciansdthat is, the
‘‘care-as-usual’’ control groupdphysicians who were pre-
sented the patients’ individual PONV risks indeed adminis-
tered more prophylactic antiemetic drugs to their patients.
However, the overall increased administration of antiemetic
prophylaxis did not result in a clinically relevant decrease
in either the overall or risk-dependent incidence of PONV.
This discrepancy was unexpected. From the results of the
trial alone, we were unable to discern between possible
causes for this discrepancy. One possible cause was that
simply presenting risk scores only had a minimal impact
on the physicians’ behavior. Other possible causes were
that the prediction model did not accurately target patients
who will respond to the antiemetic effects of the prophylac-
tic drugs or that the actual effectiveness of the prophylactic
drugs was not as high as their studied efficacy [10,11].
We hypothesized that physicians with a greater inclina-
tion to treat PONV prophylactically would have adminis-
tered more risk-dependent prophylaxis during the original
randomized controlled trial (RCT) and thus their patients
may have had a lower incidence of PONV. Hence, we per-
formed an additional mixed methods study using both
qualitative and quantitative methods to improve our under-
standing of howpredicted risks are perceived, how they influ-
ence physician decision making, and which presentation
format is considered most useful. We aimed to gain insight
in why clinical implementation of a validated and recali-
brated predictive model did not improve patient outcomes
in our example cluster RCT. Furthermore, the results of this
mixed methods study may help to formulate general recom-
mendations for the design and conduct of impact trials and
implementation of prediction models in clinical practice.2. Method
2.1. Example study
The example study was a cluster-randomized trial on the
clinical effects of implementing a prediction model for
PONV [6]. This cluster RCT included 57 physicians of the
Anesthesiology department at the UniversityMedical Center
Utrecht who treated over 11,000 patients between March 16,
2006, and December 21, 2007. After randomization of the
physicians, we compared antiemetic prescription and PONV
outcomes from the intervention group of physicians who
were ‘‘exposed’’ to their patients’ PONV risks to the
care-as-usual group. The model implementation strategy
was assistive, that is, the risk estimates were shown during
the anesthetic case, but without any patient-specific recom-
mendations on PONV prophylaxis [1,4]. During the cluster
RCT, the physicians of the intervention group administered
more risk-dependent PONV prophylaxis to their patients
than physicians of the care-as-usual group. This increase in
risk-dependent PONV prophylaxis in the intervention group
did not result in a lower incidence of PONV.
2.2. Design of the present study
The presentmixedmethods study consisted of a sequential
qualitative and quantitative phase, performed at the end of the
cluster RCT.Wefirst collected qualitative data on possible fa-
cilitators and barriers for the risk-dependent prophylactic
treatment of PONV through face-to-face, semistructured in-
terviews with physicians who participated in the cluster
RCT (December 2007). The interviews were structured ac-
cording to an interview guide constructed by the first and
third author (T.H.K. and M.A.M.K.) and were conducted
by the third author (M.A.M.K.). Interview transcripts were
analyzed by the second and first author (K.V.L. and
T.H.K.), using a grounded theory approach to identify differ-
ences in physicians’ conceptions and barriers on prophylactic
PONV management. Second, a structured survey was con-
ducted among all physicians who participated in the RCT
(January and February 2008). The interviews suggested dif-
ferences in the conceptions and barriers between physicians
of the intervention group and the care-as-usual group. There-
fore, the survey among all anesthesiologists participating in
the trial aimed to quantify whether exposure to predicted
risks as calculated by the predictionmodel resulted in similar
differences. Additional information on the methods can be
found online (Appendix A at www.jclinepi.com for the inter-
views; Appendix B at www.jclinepi.com for the survey).
2.3. Interviews
Physicians were selected for the interviews by stratified
random sampling from the pool of enrolled physicians.
Stratification allowed for selection of physicians in
different career stages (resident or junior attending vs. se-
nior attending) and different randomization statuses within
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per stratum were expected to provide sufficient variation
in the conceptions and barriers of physicians to administer
prophylactic antiemetics to their patients during general
anesthesia. In total, eight physicians were interviewed.
A semistructured interview schedule was devised using
both open and closed questions. Questions were formulated
according to four prespecified topics: (1) perceived patient
burden of PONV by the physician; (2) professional risk
stratification: how does the physician identify patients at
risk for PONV; (3) the decision-making process regarding
preventive antiemetic strategies; and (4) attitude toward
the use of prediction models and decision support for pro-
phylactic treatment of PONV. The specific phrasing and or-
der of questions were only meant as a guide; interviewer
and interviewees were encouraged to explore the different
themes during the conversation. The duration of the inter-
views ranged from 20 to 60 minutes. Data saturation was
achieved after eight interviews, and additional interviews
were not expected to provide new insights [12e14]. The in-
dividual responses to each question were sorted, coded, and
then rearranged into themes. Axial coding was used to
group the themes into broader thematic topics, using
Microsoft Excel (Redmond, Washington, USA). The themes
and topics were subsequently integrated into central themes.2.4. Structured survey
To quantify possible differences between study groups
observed during the interviews, all physicians participating
in the RCT received a Web-based survey. The survey ad-
dressed the same four topics used in the interviews. For
each topic, a specific set of questions was formulated,
and a summary score was used to rank the physicians ac-
cording to their attitude toward that particular topic. For
each question, the physicians were ranked according to
their numerical answers. The median of all rankings for a
single physician was then used as a summary ranking score
for that particular topic (see Appendix at www.jclinepi.
com). For each allocation group, the medians and interquar-
tile ranges (IQRs) of the summary ranking scores per topic
were calculated. Multiple testing was avoided by using the
median of all four summary ranking scores for each physi-
cian as an overall rank score, which was tested using a Wil-
coxon rank test. A two-sided alpha of !0.05 was
considered statistically significant.
During the interview analysis, the question arose
whether physicians from the intervention group preferred
an actionable recommendation instead of simply being pre-
sented a predicted PONV risk, anddin contrastd
care-as-usual physicians would have preferred the
prediction model over the recommendation. This question
was addressed in the survey using a post hoc analysis on
a selection of questions from ‘‘Attitudes toward prediction
models and decision support.’’ The questions which ad-
dressed either the predicted risk, a recommendation, or bothwere pooled and analyzed using a Wilcoxon rank test (see
Appendix B at www.jclinepi.com).
2.5. Adjusting the cluster-randomized trial analysis
The original RCT studied the PONV incidence (primary
outcome) and the number of prophylactic antiemetics
administered per patient (secondary outcome) for risk-
dependent differences between allocation groups using
mixed effects regression analyses [6]. We hypothesized that
physicians with a greater inclination to treat PONV prophy-
lactically would have administered more risk-dependent
prophylaxis during the original RCT and thus their patients
may have had a lower incidence of PONV. As the overall
rank score from the Web-based survey was expected to
reflect this inclination of physicians to treat PONV prophy-
lactically, we adjusted the original RCT analysis of both
outcomes for the overall rank score (see Appendix B at
www.jclinepi.com).3. Results
3.1. Interviews
The results of the eight interviews were rearranged into
17 themes according to prespecified topics of the interview
model (Tables 1e4 and Appendix A at www.jclinepi.com).
Four overarching categoriesdor central themesdemerged
from the 17 themes, which are described in the following
sections.
3.2. PONV is not a main area of attention
Awareness of PONVas a clinical problem and perceived
patient burden appeared to be low. The interviewees of both
groups reported that they considered PONV to be a side ef-
fect of general anesthesia (theme 1D, Table 1 and Appendix
A at www.jclinepi.com) and that it should not be ‘‘exces-
sively’’ treated because of a low burden relative to more
serious complications (themes 3B and 3C, Table 3). Knowl-
edge of the different elements of a PONV prevention strat-
egy appeared to be quite fragmented. There was a large
variation in reported PONV risk factors among all inter-
viewees (themes 2A and 2B, Table 2), and several inter-
viewees from both groups were reluctant to administer
either dexamethasone, droperidol, or both without being
able to explain their reluctance (theme 3A, Table 3). Addi-
tionally, it was reported not to be a regular topic of discus-
sions among the medical staff of the anesthesia department
(theme 1D, quote 14).
3.2.1. Intervention group: limited effect of the imple-
mentation strategy
The strategy for implementation of the prediction model
seemed to have resulted in a limited increase in knowledge
and awareness regarding all the aspects of PONV
Table 1. Quotes from the interview analysis on topic 1: perceived severity of PONV
No. Quote Interviewee
Theme 1A: knowledge of the frequency of PONV
1 I do not know the percentages.A number of patients, but not that many.Actually, I do
not see it [author’s note: PONV] that often. No, I do not see many patients who get
nauseous.The percentage [author’s note: percentage of PONV] is not that high, so
might I say 1 in 10? Well, no, I don’t know.
Senior attending, care-as-usual group
Theme 1B: perception of the frequency of PONV among their patients
2 It occurs in more than 1 out of 3 patients. And yes, I do believe that is a lot. Resident, intervention group
3 You see, that is my experience of late, as I now mostly provide anesthesia for
neurosurgical procedures. They do become nauseous, but because of the type of
procedure, in fact, I don’t see it that often.
Senior attending, care-as-usual group
4 The risk of PONV, because of the things we do, is quite large. Senior attending, care-as-usual group
Theme 1C: feedback on PONV occurrence in their patients increases awareness
5 Well, I received those numbers from the researchers, and they were shockingly higher
than I expected.
Senior attending, intervention group
6 .I am more aware of PONV, I administered more prophylaxis and it did not change a
thing. So I thought to myself, this is not getting us anywhere.
Senior attending, intervention group
7 I try to pay attention that I administer e to my opinion e adequate prophylaxis and
adjust my anesthetic technique to lower the occurrence of PONV.
Resident, intervention group
8 About 40 to 50% of my patients suffer from PONV. I know that from the feedback
reports, otherwise I would not have known.
Senior attending, intervention group
9 Of course I see my patients at the postanesthesia care unit, but I rarely hear back from
the nursing ward when my patients get nauseous.
Senior attending, care-as-usual group
Theme 1D: PONV is a side effect of general anesthesia
10 As an anesthesiologist you know that, because of the things you do, you structurally
increase the patient’s risk of PONV.
Senior attending, care-as-usual group
11 It is inherent to our procedures, I mean, when you are on the bus for a holiday, and you
get nauseous because it is a bumpy ride, do you consider that a complication or is it
just a part of the bus trip because you are sensitive to motion sickness?
Senior attending, care-as-usual group
12 It is different when the vomiting is that severe that it damages the esophagus, or
something like that. Then it could turn into a complication.
Senior attending, care-as-usual group
13 PONV is a side effect of anesthesia and surgery, but if it is too easily overlooked and its
prevention is insufficiently being addressed, then one might call it a medical error
and consider it a complication.
Junior attending, intervention group
14 Because of the study it [author’s note: awareness of PONV] has increased a little bit.
However, it is still not a problem which is regularly brought up during case
discussions. Perhaps it is just something that slips your mind quite easily.
Resident, intervention group
Abbreviation: PONV, postoperative nausea and vomiting.
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the interviewees from the intervention group seemed to be
more aware of the frequency of PONV, as compared with
the interviewees from the care-as-usual group (themes 1A
and 1B). On the other hand, interviewees from the interven-
tion group seemed only a little more aware of the efficacy
of prophylactic antiemetics (theme 3A), whereas knowl-
edge of other aspects of PONV prevention was similar in
both study groups (themes 2A and 2B).3.3. Unconscious process of decision making
For most physicians, the process of deciding on PONV
prophylaxis is implicit. Physicians usually weighed several
factors in their decision to administer prophylactic anti-
emetics: they made a risk assessment based on patient
and procedure characteristics (themes 2A and 2B, Table 2
and Appendix A at www.jclinepi.com) and subsequently
weigh the risk against benefits, harms, and contraindica-
tions of antiemetics (themes 3A and 3C, Table 3). The phy-
sicians did not report a well-defined process of assessingand weighing all these factors (themes 2C and 3B), so
the process predominantly takes place ‘‘unconsciously’’d
or intuitively.
3.4. Presenting predicted PONV risks may not be
sufficient to change professional decisions
Although interviewees from the intervention group
reported to use the predicted risks in their decisions on
PONV prophylaxis, they were unable to explicate how
they used the predicted risk in their decisions on PONV
prophylaxis (theme 4B, Table 4 and Appendix A at
www.jclinepi.com). The interviewees from the interven-
tion group expected that when a recommendation on
PONV prophylaxis would be added to the predicted
PONV risk, they would usually follow the advice (theme
4G, quotes 42 and 43). In contrast, the interviewees from
the care-as-usual group reported that they would
consider the presented risk of PONV mainly as a
reminder (theme 4C) and that a recommendation on
PONV prophylaxis would not have much added value
(theme 4G, quotes 39e41).
Table 2. Quotes from the interview analysis on topic 2: professional risk stratification: how does a physician identify patients at risk for PONV?
No. Quote Interviewee
Theme 2A: variation in the use of risk factors
15 When you see a very stressed and anxious young woman who is scheduled for a
laparoscopy, then you immediately think: this will probably be Bingo.
Senior attending, intervention group
16 Yes, people with a history of PONV. People that claim: ‘I am always terribly nauseous’. It
almost seems like a self-fulfilling prophecy.
Senior attending, intervention group
Theme 2B: risk factors may be experience based or evidence based
17 Yes, my assessment is based on literature.Relying on your own experience can be quite
treacherous, because most patients get nauseous at the nursing ward, not at the
postanesthesia care unit, and I do not regularly visit all my patients at the nursing ward.
Resident, care-as-usual group
18 So these are risk factors known from literature, but I do not take them into account to
decide on who will become nauseous.For example smoking, if it has any consequences
for my anesthetic case, I prefer to consider its pulmonary effects.
Senior attending, care-as-usual group
Theme 2C: weighing different risk factors: no clear-cut risk appraisal
19 No, it is not a conscious process. It is more that you roughly know the risk factors, you have
an overall view of the patient, and then you start thinking: Does this patient has a high
risk or not? But in my mind, I am not actually calculating the risk.
Resident, intervention group
20 Just an intuitive feeling: this person will probably suffer from PONV. Senior attending, care-as-usual group
Abbreviation: PONV, postoperative nausea and vomiting.
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stated preference for an actionable recommendation by
intervention group interviewees suggested that being pre-
sented only with a predicted risk may be difficult to use
in a clinical decision. Adding a risk-corresponding treat-
ment recommendation may assist physicians in interpreting
the predicted risk for a decision on PONV prophylaxis
(theme 4G, quote 43).3.5. Multifaceted and individualized decision making
The physicians of both groups reported one distinct bar-
rier for using a prediction model: they felt that a prediction
model does not take into account all aspects of a specific
patient. The prediction model only predicted the risk forTable 3. Quotes from the interview analysis on topic 3: making decisions on
No. Quote
Theme 3A: perceived benefits and harms of prophylactic antiemetic strateg
21 The only drug that I actually administer as prophylaxis and for whic
is ondansetron.
22 Well, when your risk is 60% at first and afterward a risk of 40%, the
23 Dexamethasone? Definitely not as prophylaxis. That stuff has too
not believe that it actually works that well.
24 Patients who always become nauseous after surgery, I always just
and it works, yes it works really well..No, I don’t see many sid
25 There are people who say that a single dose of dexamethasone is
people claim that even a single dose may cause serious side ef
26 There is definitely added value for droperidol, I think that is a goo
droperidol intraoperatively.It provides some drowsiness, but in
is hardly a problem.
Theme 3B: decisions on PONV prophylaxis are made implicitly
27 You see, you can prevent nausea for a number of people, but whe
suffering from a surgical site infection [author’s note: a perceiv
PONV prophylaxis], your net benefit is lost.
Theme 3C: PONV prophylaxis: only when indicated
28 Let’s put it this way: to systematically provide PONV prophylaxis t
because of the side effects. Although, when indicated for a spe
can accept the side effects.
Abbreviation: PONV, postoperative nausea and vomiting.a specific outcome and did not weigh the benefit of treat-
ment against the expected harms and contraindications for
a particular patient with specific characteristics and co-
morbidity (theme 4E, Table 4 and Appendix A at www.
jclinepi.com). Furthermore, the physicians indicated that
even a patient-specific risk prediction is not truly patient
specific. The predicted PONV risk is an overall risk and
does not reflect the specific pathway for becoming
nauseous (theme 4F). The physicians felt that decision
support should not be implemented at the cost of their au-
thority to make case-by-case decisions. It is a physician’s
responsibility to make an individualized decision whether
treatment of a specific condition is warranted for his or her
patientdeven when they decide against the recommenda-
tion (theme 4D).prophylactic antiemetic strategies
Interviewee
ies
h I don’t feel any reluctance Junior attending, care-as-usual group
n it is about 20% effective. Resident, intervention group
many side effects. And I do Senior attending, care-as-usual group
give them dexamethasone,
e effects of that.
Senior attending, intervention group
not so bad, whereas other
fects.
Junior attending, intervention group
d drug..I rarely administer
the low dose that we give, it
Senior attending, intervention group
n opposed by one person
ed risk of dexamethasone
Junior attending, care-as-usual group
o all patients is impossible,
cific patient, I believe you
Senior attending, care-as-usual group
Table 4. Quotes from the interview analysis on topic 4: attitude toward the use of prediction models and decision support
No. Quote Interviewee
Theme 4A: intervention group: the predicted PONV risk is higher than their own risk assessment
29 And I believe the predicted risks were higher because the prediction model actually
calculates the risk from all factors associated with PONV, whereas we anesthesiologists
lean toward particular touchstone factors such as history of PONV and type of surgery.
Junior attending, intervention group
Theme 4B: intervention group: no conscious roadmap for using the predicted risk
30 When you open the anesthesia information management system, you immediately see it.
Well, it is not that I immediately am consciously aware of it, sometimes I am, but not
always. It occasionally happens that at the end of the procedure you think: ‘O yes, the
risk was high, shall I.
Senior attending, intervention group
31 Yes, well, when I entered the study and I received these predicted risks, I did use them for a
while.I used the numbers to decide whether or not I would administer prophylaxis.
Lately, I obviously eased on doing that, and I cannot clearly explain why that happened.
Junior attending, intervention group
Theme 4C: care-as-usual group: the predicted risk is mainly a reminder
32 You know, it is foremost a reminder.Something in your screen that says:
‘Remember!’.You are supposed to think of everything, sometimes you just fall short. So
when it is on by default.
Senior attending, care-as-usual group
33 You do not benefit that much from a predicted risk. It is more a way to direct your attention
to PONV, because to actually solve the problem itself you need more details than just a
predicted risk.
Senior attending, care-as-usual group
Theme 4D: authority in making decisions is more important than decision support
34 There is nothing wrong with a recommendation, as long as it does not become compulsory. Junior attending, care-as-usual group
35 Of course it is nice to get a recommendation. On the other hand, all doctors, including me,
feel that they can decide for themselves. I am in charge and I am also responsible.
Senior attending, intervention group
Theme 4E: prediction models do not consider other comorbidity
36 The recommendation is probably only aimed at PONV, so I do believe that you should
continue to consider which patient you have in front of you and what drugs you are going
to administer.
Resident, intervention group
37 You may consider giving the patient dexamethasone as prophylaxis, but it may be
contraindicated for specific patients or specific procedures.
Senior attending, care-as-usual group
Theme 4F: the predicted risk does not reflect the underlying mechanisms of PONV
38 You can only treat a patient when you know the actual cause of the problem. Without that,
the predicted risk will not do you any good, you need to know which factors contributed to
that particular risk.
Senior attending, care-as-usual group
39 You need to know which factors contributed to that particular risk and then a
recommendation may follow. However, as the treating physician you may regard this
recommendation solely as an advice.
Senior attending, care-as-usual group
Theme 4G: willingness to use decision support may be dependent on familiarity
40 We already have a protocol which antiemetic drugs to administer, so in its essence a
predicted probability should suffice.
Junior attending, care-as-usual group
41 When you are sufficiently informed on its background, you can use the recommendation to
your advantage. The question remains whether all the efforts which precede the
implementation are actually worth their while.
Senior attending, care-as-usual group
42 I believe I would be inclined to administer more PONV prophylaxis, because you know that
the predicted risk is based on an extensive calculation using several factors.
Junior attending, intervention group
43 On one hand it is nice to treat a patient based on a true evidence-based recommendation,
on the other hand all doctors want to decide for themselves.So I have mixed feelings
about this. I believe it will be a matter of getting used to it. At a certain point it will
become a custom, and especially when it is has been proven to work, you would be a fool
not to follow the recommendation.
Senior attending, intervention group
Abbreviation: PONV, postoperative nausea and vomiting.
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In the original RCT, there were baseline differences in
the characteristics of the physicians across the two groups
(Table 5) [6]. Although none of these differences were sta-
tistically significant (also due to small numbers), the differ-
ences seemed large and clinically relevant and were the
probable cause of the baseline differences at the patient
level in the original RCT. Of the 57 physicians analyzed
in the original RCT, 53 (93%) completed the survey[intervention group 29 (94%) and care-as-usual 24
(92%)]. Overall, the physicians of the intervention group
had higher overall rank scores than the physicians of the
care-as-usual group [median 31 (IQR 17e29) vs. 25 (IQR
24e37); P ! 0.05]. This difference in rank scores indi-
cated that intervention group physicians had a more posi-
tive attitude toward PONV prevention and the risk-
dependent administration of PONV prophylaxis (Table 6).
Similar to the results of the interviews, the post hoc
Table 5. Baseline characteristics of physicians from the survey
Characteristics
Care-as-usual
group (n [ 26)a
Intervention
group (n [ 31)a
Number of patients treated,
median (IQR)
170 (128e300) 162 (120e207)
Age,b y; mean (SD) 43 (9) 43 (10)
Female sex, n (%) 11 (42) 15 (48)
Entered during study, n (%) 5 (19) 8 (26)
Left department during study,
n (%)
4 (15) 7 (23)
Speciality
Cardiac anesthesia,b n (%) 2 (8) 2 (6)
Pediatric anesthesia,b n (%) 3 (12) 4 (13)
Pain medicine,b n (%) 1 (4) 4 (13)
Senior resident,b n (%) 12 (46) 11 (35)
Entered as senior resident
during study, n (%)
4 (15) 4 (13)
Senior resident became
attending anesthesiologist
during study, n (%)
5 (19) 4 (13)
Risk (%) threshold for
administering PONV
prophylaxis,b median (IQR)
30 (30e40) 30 (20e50)
Abbreviations: IQR, interquartile range; PONV, postoperative
nausea and vomiting; SD, standard deviation.
a Number of physicians who participated in the cluster-
randomized trial and were eligible for the survey.
b Characteristic was documented at the moment of inclusion in
the study.
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indicated that the intervention group physicians had a













0.89 22 (13e30) 33 (18e41)
Topic 2: professional
risk stratification




0.72 24 (17e36) 30 (25e34)
Topic 4: attitude toward
prediction models
0.49 29 (17e32) 29 (17e41)
Overall ranking score 25 (17e29)b 31 (24e37)b
Ranking score for
topics 1e3c
22 (17e28) 34 (25e39)
Abbreviation: PONV, postoperative nausea and vomiting.
Data represent the medians (interquartile ranges) of the physi-
cians’ rankings scores within a study group for that topic. The scores
indicate a ranking on a scale from 1 to 53 (the number of physicians
who completed the survey). Higher ranking scores indicate physicians
who have more favorable attitude toward the topic as compared with
physicians with lower ranking scores.
a Physicians who completed the survey.
b P ! 0.05.
c As there was no difference between groups for ‘‘Attitudes toward
prediction models’’ and the topic had a low internal consistency, the
combined rank score for the other three topics without ‘‘Attitudes to-
ward prediction models and decision support’’ was also reported.statistically significant (median score intervention group 1
and care-as-usual group 0; P ! 0.05).
3.6.1. Adjusting the cluster-randomized trial analysis
When the original regression analyses were adjusted for
the overall rank score of the survey, results were similar to
the original results for both the primary and secondary out-
comes (see Appendix B at www.jclinepi.com, Table 5).
There was no association between the overall rank score it-
self and the incidence of PONV [odds ratio, 1.00; 95% con-
fidence interval (CI): 1.00, 1.01] or the administration of
prophylactic antiemetics (rate ratio, 1.00; 95% CI: 1.00,
1.01).4. Discussion
We studied how the implementation and use of an
assistive prediction model allowed physicians to apply
risk-tailored prevention or treatment strategies and identi-
fied facilitators and barriers for risk-tailored management.
In our example study, the implementation of the prediction
model for PONV facilitated physicians in three ways: the
physicians became more aware of the outcome PONV, were
better informed on its risk factors, and had a more positive
attitude toward preemptive management of PONV. Never-
theless, the facilitating effect of the prediction model on
actual behaviordand thus patient outcomesdwas modest.
Physicians reported several barriers for using risk predic-
tions from a prediction model, which may haveBox 1 Summary box
Barriers for using risk prediction models in clinical
practice
The predicted outcome is not a main area of attention for
the physicians.
The decision-making process of physicians is intuitive
rather than analytical.
The probabilistic knowledge of the outcome is difficult to
use in decision making, certainly when the probability
estimate it is not accompanied by corresponding (e.g.,
therapeutic) management recommendations (assistive
prediction model).
A prediction model does not weigh the benefits and risks
of prophylactic drugs with regard to the patient’s
comorbidity.
Recommendations for a successful implementation of a
prediction model in clinical practice
Adding an actionable recommendation to the predicted
risk (directive prediction model).
Presentation of the predicted risk should be automated
and smoothly integrated with the physician’s workflow.
The reasoning and research evidence of the underlying
prediction model to show how risks are actually
estimated should also be available to physicians.
A prediction model will be better perceived by physicians
when it predicts outcomes that are relevant to them and
their patients.
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predicted outcomedthat is, PONVdwas not a main area
of attention for most physicians. Second, the physicians
did not use a conscious process for making decisions on
PONV prophylaxis. Third, the presentation of only
outcome risks or probabilitiesdthat is, without further ther-
apeutic management guidancedmade it difficult to link the
proper management to the predicted risks in individual pa-
tients. Fourth, a prediction model does not weigh the ben-
efits and risks of prophylactic drugs with regard to the
patient’s comorbidity. The physicians argued that adminis-
tration of PONV prophylaxis should remain an individual-
ized decision made by a physician not by a model.
Furthermore, physicians who indicated to be more inclined
to treat PONV prophylactically did not administer more
prophylaxis to their patients than physicians with a lesser
inclination. This suggests that the facilitating effects of
the prediction model were too modest to overcome the re-
ported barriers, which also agrees with the original results
of the study, as described elsewhere [6].
From this example study, we can learn how physicians
may act on the use of risk prediction models to guide their
decision making in individual patients. The data suggest
that the clinical decision-making process may be much
more intuitive than physicians realize. In other words, it
may well be that physicians are typically habitual in their
actions and little decision making is involved. In cognitive
psychology literature, this intuitive, nonanalytical process
of decision making is referred to as a ‘‘system 1’’ process,
as opposed to conscious and analytical reasoning, referred
to as a ‘‘system 2’’ process [15e17]. Humans have a higher
capacity for reasoning when they use the rapid system 1
processes instead of the much slower system 2 processes.
The results of our study further indicate that only present-
ing the model’s predicted risksdwithout corresponding
treatment recommendationsdwill generally force doctors
to use system 2 type reasoning. Physicians have to become
more reflective to integrate their clinical experience with
the probabilistic information from the prediction model
and translate this into a meaningful decision on subsequent
actions and management, weighing all benefits and harms
for a particular patient. This may actually be a difficult
and cognitively demanding task, which makes the predic-
tion tool seem less useful to physicians.
One might argue that this process is exactly what clin-
ical judgment is about and that it is a physician’s job to
make such complicated decisions [18e20]. However, in
our study, the physicians also reported that the outcome
PONV was not a main area of attention. This barrier (see
Box 1) may work in two ways. First, ‘‘attention’’ refers
to information processes and task performance as it is used
in human factors and ergonomics and is related to workload
[21,22]. Clinical decision making is an intricate task per-
formed within a system with a high degree of competing in-
formation and a multitude of tasks [23e25]. Consequently,
integrating an outcome risk into an otherwise intuitivedecision process requires a lot of ‘‘attention’’ in an already
demanding environment. Second, PONV as an area of
attention may refer to the physicians’ knowledge of this
particular condition or the perception of an outcome with
limited patient burden [26]. In anesthesiology, PONV is
considered the ‘‘big little problem’’dthat is, frequent but
not life threateningdin a network of other anticipated
and possibly more severe consequences [27,28]. It is imag-
inable that physicians will prioritize their attention to pre-
ventable problems with a higher perceived burden than to
preventable problems with a lower perceived burden [29].
In addition, when the perceived burden is lower, the
possible benefit is also lower and is thus more easily out-
weighed by the risk of adverse effects of treatment. Specific
comorbidity may increase the risk of adverse treatment ef-
fects for individual patientsdfor example, dexamethasone
use in diabetic patients or immunocompromised patientsd
yet the prediction model does not account for the comorbid-
ities that are related to the adverse effects. When physicians
believe that the predictive tool does not facilitate individu-
alized decision making (the fourth barrier, see Box 1), they
will be even less inclined to spend their time and attention
to use the predicted outcome risks in their decisions.
The concept of how the three barriers may hinder physi-
cians from using prediction models in their clinical deci-
sions leads us to several recommendations for a
successful implementation of a predictive tool in clinical
practice and thus for the conduct of impact trials (see
Box 1).
First, the demand that a predictive tool poses on the atten-
tion of physicians may be reduced by adding treatment rec-
ommendations to the presented predicted risks or risk
categories, as it reduces the cognitive effort required to
translate the predicted risk into a clinical decision. Prompted
by the results of this qualitative study, we recently per-
formed an add-on study to the cluster RCT, in which we
actually added therapeutic recommendations to specific cat-
egories of predicted outcome riskdthat is, a directive imple-
mentation approach. The directive approach had indeed a
much larger effect on the decision making as well as on
the reduction in outcome incidence than the assistive imple-
mentation approach had in the preceding cluster RCT [30].
Adding therapeutic recommendations to predicted risks
to increase the uptake of decision support has been recom-
mended before by various authors, including by ourselves
[1,31e36]. However, these recommendations were either
made in a more qualitative, editorial way, or came from
systematic reviews that compared large numbers of studies
for the features that facilitated implementation of decision
support. We believe that our article adds novel concepts
to this literature. In contrast to the systematic reviews that
compared a large variety of clinical problems and settings,
our series of studies (cluster RCT, this manuscript, and the
beforeeafter study) provide a head-to-head comparison of
decision support without and with treatment recommenda-
tions within the same clinical setting. Moreover, most of the
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use of recommendations to a change in behavior without
providing an actual explanation why. Our results indicate
that it is not per se the ease of use of a recommendation that
facilitates implementation but that a predicted risk without
a recommendation prevents uptake by physicians to a
greater extent.
Second, automatic provision of the predicted risk that is
smoothly integrated with the physician’s workflow may
also be a key factor to reduce the required amount of atten-
tion and promote the use of the predicted outcome risks
[33,34,37e40]. Third, a predictive tool may better aid phy-
sicians in making individualized decisions when the
reasoning and research evidence that resides behind the tool
is also presented to the physicians [33,34,37,39,41]. When
physicians are better informed of which factors actually
contribute to a predicted risk for a particular outcome, it
is easier for them to understand how the predicted risk re-
lates to their clinical experience. It was beyond the scope of
this article to determine whether making physicians better
informed would indeed improve their decision making or
that the preference of the physicians for more information
was an expression of overconfidence [18,19,42e44].
Finally, a predictive tool will likely be better perceived
by physicians when it predicts outcomes that are relevant
to them and their patients.
There are several limitations to our study. First, the re-
sults do provide a plausibledbut not definitived
explanation for the ‘‘no-effect-result’’ of our cluster RCT.
Second, the internal consistency for topic four (i.e., ‘‘Atti-
tude toward prediction models’’) was relatively low. Conse-
quently, topic four was of much less importance to the
survey than the other three topics of the survey, as their in-
ternal consistencies were good (Cronbach’s alpha between
0.70 and 0.90). The results of the survey thus mainly reflect
the first three topics (i.e., ‘‘Perceived burden of PONV’’;
‘‘Professional risk stratification’’; and ‘‘Making decisions
on prophylaxis’’). Third, we do not know what the role of
the identified barriers was in specific decisions on PONV
prophylaxis for individual patients. For example, we do
not know how specific comorbidities or predictive factors
influenced the physicians’ decision making for individual
patients or under what workload conditions those decisions
were made. Fourth, we performed the interviews and sur-
veys at the end of the RCT. That poses the problem that
the interviews are based on hindsight and that not every-
thing may be accurately recollected by the physicians.
Fortunately, at the time of the interviews and surveys, the
physicians were still making decisions on PONV prophy-
laxis in their daily practice, yet without the prediction
model. Their responses to most of the questions likely still
represented their actual decision making. Fifth, we dis-
cussed that integrating clinical experience with the probabi-
listic knowledge from the prediction model may be a
demanding task. We cannot discern from our results
whether this task is demanding because the physicians findit to be ‘‘simply too much work’’ or because the physicians
do not know how their clinical experience may be inte-
grated with the predicted risk.
In summary, we studied facilitators and barriers in the
use of clinical prediction and decision models using a large
randomized study on the implementation of a prediction
model for PONV. Conscious integration of a predicted risk
into the doctor’s decision-making process may be difficult
when the decision-making process is mostly intuitive and
implicit. In a high-workload environment, such integration
may require too much attention from a physician to actually
integrate clinical and probabilistic knowledge. When one
wishes to implement a prediction model to improve clinical
practice, an important consideration is how to accommo-
date the new information in the physicians’ workflow and
how to ease the demand of attention on the physicians.
Adding actionable patient-management recommendations
to the predicted risk categories and providing physicians
with the reasoning behind the predicted risks are the first
steps to reduce such demand and improve the uptake of
clinical prediction models in practice.Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.jclinepi.2015.09.008.
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